Published by Josh White on 10th January 2025
(Sharecast News) - Arecor Therapeutics announced plans to cease operations within its subsidiary Tetris Pharma during 2025 on Friday, adding that it had mutually agreed with Xeris BioPharma to return the rights to Ogluo - a ready-to-use glucagon auto-injector for severe hypoglycemia.
URL: http://www.digitallook.com/dl/news/story/34805014/...